SUPERSTRING CAPITAL MANAGEMENT LP DNA — GINKGO BIOWORKS HOLDINGS INC

Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP  ·  1 quarter on record

AI Ownership Summary

SUPERSTRING CAPITAL MANAGEMENT LP reported GINKGO BIOWORKS HOLDINGS INC (DNA) in 1 quarterly 13F filing from 2026 Q3 through 2026 Q3. Peak portfolio weight reached 1.43% in 2026 Q3. The latest visible filing shows DNA at 1.43% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this DNA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was SUPERSTRING CAPITAL MANAGEMENT LP's position in GINKGO BIOWORKS HOLDINGS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q3

DNA was reported at 1.43% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.43% in 2026 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2026 Q3 to 2026 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How SUPERSTRING CAPITAL MANAGEMENT LP held DNA — position size vs. price
% of Fund (quarterly)    DNA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 1 quarter  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q3 INITIATED — — — 222,553 — — 1.43% $2.9M 2026-11-16 $8.50

FAQ About SUPERSTRING CAPITAL MANAGEMENT LP and DNA

These are the practical questions this page is built to answer before you even open the full history table.

How long has SUPERSTRING CAPITAL MANAGEMENT LP reported owning DNA?

SUPERSTRING CAPITAL MANAGEMENT LP reported DNA across 1 quarterly 13F filings, from 2026 Q3 through 2026 Q3.

What was the largest reported DNA position in SUPERSTRING CAPITAL MANAGEMENT LP's portfolio?

The largest reported portfolio weight for DNA was 1.43% in 2026 Q3.

What is the latest reported DNA position on this page?

The most recent filing on this page is 2026 Q3, when SUPERSTRING CAPITAL MANAGEMENT LP reported 222,553 shares, equal to 1.43% of portfolio, with an estimated market value of $2.9M.

What does the chart on this DNA ownership page compare?

The chart compares SUPERSTRING CAPITAL MANAGEMENT LP's quarterly DNA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to SUPERSTRING CAPITAL MANAGEMENT LP Holdings